Phosphogluconate dehydrogenase (decarboxylating) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Phosphogluconate dehydrogenase (decarboxylating)" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

13doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

2harvard.edu

18^th place

17^th place

1iucr.org

low place

9,593^rd place

1ntu.edu.tw

2,798^th place

4,271^st place

doi.org

Phillips C, Gover S, Adams MJ (1995). "Structure of 6-phosphogluconate dehydrogenase refined at 2 Å resolution" (PDF). Acta Crystallogr. D. 51 (3): 290–304. Bibcode:1995AcCrD..51..290P. doi:10.1107/S0907444994012229. PMID 15299295.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
Chen YY, Ko TP, Chen WH, Lo LP, Lin CH, Wang AH (2010). "Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from Escherichia coli and Klebsiella pneumoniae: Implications for enzyme mechanism" (PDF). J. Struct. Biol. 169 (1): 25–35. doi:10.1016/j.jsb.2009.08.006. PMID 19686854.
Rippa M, Giovannini PP, Barrett MP, Dallocchio F, Hanau S (1998). "6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species". Biochim. Biophys. Acta. 1429 (1): 83–92. doi:10.1016/S0167-4838(98)00222-2. PMID 9920387.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540. S2CID 20352349.
Martins RN, Harper CG, Stokes GB, Masters CL (1986). "Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress". J. Neurochem. 46 (4): 1042–1045. doi:10.1111/j.1471-4159.1986.tb00615.x. PMID 3950618. S2CID 337317.
Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995). "Persistent oxidative stress in cancer". FEBS Lett. 358 (1): 1–3. Bibcode:1995FEBSL.358....1T. doi:10.1016/0014-5793(94)01368-B. PMID 7821417. S2CID 16090349.
Nerurkar VR, Ishwad CS, Seshadri R, Naik SN, Lalitha VS (1990). "Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors". J. Comp. Pathol. 102 (2): 191–195. doi:10.1016/S0021-9975(08)80124-7. PMID 2324341.
Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540. S2CID 20352349.
Dardonville C, Rinaldi E, Hanau S, Barrett MP, Brun R, Gilbert IH (2003). "Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis". Bioorg. Med. Chem. 11 (14): 3205–14. doi:10.1016/S0968-0896(03)00191-3. PMID 12818683.
Hanau S, Rinaldi E, Dallocchio F, Gilbert IH, Dardonville C, Adams MJ, Gover S, Barrett MP (2004). "6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes". Curr. Med. Chem. 11 (19): 2639–50. doi:10.2174/0929867043364441. PMID 15544466.

harvard.edu

ui.adsabs.harvard.edu

Phillips C, Gover S, Adams MJ (1995). "Structure of 6-phosphogluconate dehydrogenase refined at 2 Å resolution" (PDF). Acta Crystallogr. D. 51 (3): 290–304. Bibcode:1995AcCrD..51..290P. doi:10.1107/S0907444994012229. PMID 15299295.
Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995). "Persistent oxidative stress in cancer". FEBS Lett. 358 (1): 1–3. Bibcode:1995FEBSL.358....1T. doi:10.1016/0014-5793(94)01368-B. PMID 7821417. S2CID 16090349.

iucr.org

journals.iucr.org

Phillips C, Gover S, Adams MJ (1995). "Structure of 6-phosphogluconate dehydrogenase refined at 2 Å resolution" (PDF). Acta Crystallogr. D. 51 (3): 290–304. Bibcode:1995AcCrD..51..290P. doi:10.1107/S0907444994012229. PMID 15299295.

nih.gov

pubmed.ncbi.nlm.nih.gov

Phillips C, Gover S, Adams MJ (1995). "Structure of 6-phosphogluconate dehydrogenase refined at 2 Å resolution" (PDF). Acta Crystallogr. D. 51 (3): 290–304. Bibcode:1995AcCrD..51..290P. doi:10.1107/S0907444994012229. PMID 15299295.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
Chen YY, Ko TP, Chen WH, Lo LP, Lin CH, Wang AH (2010). "Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from Escherichia coli and Klebsiella pneumoniae: Implications for enzyme mechanism" (PDF). J. Struct. Biol. 169 (1): 25–35. doi:10.1016/j.jsb.2009.08.006. PMID 19686854.
Rippa M, Giovannini PP, Barrett MP, Dallocchio F, Hanau S (1998). "6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species". Biochim. Biophys. Acta. 1429 (1): 83–92. doi:10.1016/S0167-4838(98)00222-2. PMID 9920387.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540. S2CID 20352349.
Martins RN, Harper CG, Stokes GB, Masters CL (1986). "Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress". J. Neurochem. 46 (4): 1042–1045. doi:10.1111/j.1471-4159.1986.tb00615.x. PMID 3950618. S2CID 337317.
Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995). "Persistent oxidative stress in cancer". FEBS Lett. 358 (1): 1–3. Bibcode:1995FEBSL.358....1T. doi:10.1016/0014-5793(94)01368-B. PMID 7821417. S2CID 16090349.
Nerurkar VR, Ishwad CS, Seshadri R, Naik SN, Lalitha VS (1990). "Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors". J. Comp. Pathol. 102 (2): 191–195. doi:10.1016/S0021-9975(08)80124-7. PMID 2324341.
Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540. S2CID 20352349.
Dardonville C, Rinaldi E, Hanau S, Barrett MP, Brun R, Gilbert IH (2003). "Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis". Bioorg. Med. Chem. 11 (14): 3205–14. doi:10.1016/S0968-0896(03)00191-3. PMID 12818683.
Hanau S, Rinaldi E, Dallocchio F, Gilbert IH, Dardonville C, Adams MJ, Gover S, Barrett MP (2004). "6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes". Curr. Med. Chem. 11 (19): 2639–50. doi:10.2174/0929867043364441. PMID 15544466.

ncbi.nlm.nih.gov

He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.
He W, Wang Y, Liu W, Zhou CZ (2007). "Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1". BMC Struct. Biol. 7: 38. doi:10.1186/1472-6807-7-38. PMC 1919378. PMID 17570834.

ntu.edu.tw

ntur.lib.ntu.edu.tw

Chen YY, Ko TP, Chen WH, Lo LP, Lin CH, Wang AH (2010). "Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from Escherichia coli and Klebsiella pneumoniae: Implications for enzyme mechanism" (PDF). J. Struct. Biol. 169 (1): 25–35. doi:10.1016/j.jsb.2009.08.006. PMID 19686854.

semanticscholar.org

api.semanticscholar.org

Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540. S2CID 20352349.
Martins RN, Harper CG, Stokes GB, Masters CL (1986). "Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress". J. Neurochem. 46 (4): 1042–1045. doi:10.1111/j.1471-4159.1986.tb00615.x. PMID 3950618. S2CID 337317.
Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995). "Persistent oxidative stress in cancer". FEBS Lett. 358 (1): 1–3. Bibcode:1995FEBSL.358....1T. doi:10.1016/0014-5793(94)01368-B. PMID 7821417. S2CID 16090349.
Palmer AM (1999). "The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease". J. Neural Transm. 106 (3–4): 317–328. doi:10.1007/s007020050161. PMID 10392540. S2CID 20352349.